Phase I and pharmacokinetic study of MS-275, a histone deacetylase inhibitor, in patients with advanced and refractory solid tumors or lymphoma (Q46455509)
Jump to navigation
Jump to search
scientific article published on 25 April 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I and pharmacokinetic study of MS-275, a histone deacetylase inhibitor, in patients with advanced and refractory solid tumors or lymphoma |
scientific article published on 25 April 2005 |
Statements
1 reference
Phase I and pharmacokinetic study of MS-275, a histone deacetylase inhibitor, in patients with advanced and refractory solid tumors or lymphoma (English)
1 reference
Alex Sparreboom
1 reference
Jane B Trepel
1 reference
Qin C Ryan
1 reference
Donna Headlee
1 reference
Milin Acharya
1 reference
Joseph Ye
1 reference
William D Figg
1 reference
Kyunghwa Hwang
1 reference
Eun Joo Chung
1 reference
Anthony Murgo
1 reference
Giovanni Melillo
1 reference
Yusri Elsayed
1 reference
Manish Monga
1 reference
Mikhail Kalnitskiy
1 reference
James Zwiebel
1 reference
Edward A Sausville
1 reference
25 April 2005
1 reference
23
1 reference
17
1 reference
3912-3922
1 reference